What is Scargo Labs?
Based in California, Scargo Labs operates as the state's first GMP-certified CBD and CBG manufacturing and extraction facility. The company distinguishes itself through a commitment to pharmaceutical-grade refinement processes and rigorous laboratory testing protocols. By leveraging advanced extraction methodologies, Scargo Labs maintains a production capacity of up to 10,000 kg per month, utilizing American-grown industrial hemp to ensure supply chain integrity. Their business model spans both wholesale distribution and direct-to-consumer channels, providing high-purity extracts that prioritize safety, efficacy, and health-conscious formulation standards.
How much funding has Scargo Labs raised?
Scargo Labs has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Scargo Labs
PPP
Public-Private Partnership
What's next for Scargo Labs?
With the infusion of this latest capital, Scargo Labs is positioned to accelerate its industrial footprint and optimize its manufacturing throughput. The strategic focus will likely shift toward scaling its GMP-compliant infrastructure to meet the rising demand for high-quality cannabinoid ingredients in the pharmaceutical and wellness sectors. By enhancing its refinement technologies, the firm aims to further differentiate its product offerings, ensuring that it remains at the forefront of the evolving regulatory and quality-assurance landscape for hemp-derived extracts. Future growth will be defined by the company's ability to maintain its rigorous testing standards while expanding its wholesale reach across the North American market.
See full Scargo Labs company page
